EUVIMEDEUVIMED entdecken
Crossref

The implications of supraphysiological testosterone supplementation

Alice T Chu, Akanksha Mehta

The Journal of Sexual Medicine · 2024

DOI: 10.1093/jsxmed/qdad179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Sexual Medicine, 2024. Verfasst von Alice T Chu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Emory University School of Medicine, Atlanta, GA 30332, United States. Hauptthemen laut MEDLINE: Testosterone, Hypogonadism. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testosterone deficiency is common among aging men and causes a variety of sexual, psychological, and physical symptoms. The popularity of hormone replacement with steroids such as testosterone is relatively recent, with most literature on its effect, appropriate use, and risks published in the past 30 years. Professional society guidelines do recommend treating low testosterone in the presence of symptoms or signs of hypogonadism. Both the American Urological Association and European Academy of Andrology recommend testosterone replacement therapy to treat symptomatic testosterone deficiency, with a target testosterone level in the midnormal range. While the absolute numbers in this range may differ depending on the laboratory, the middle tertile is commonly agreed to be within the 450-600 ng/dL range. There is high-quality evidence to support testosterone correction to the eugonadal range: this range is viable for all age groups of men, and levels in this range usually ameliorate symptoms of testosterone deficiency. The TTrials, published in 2018, were a coordinated set of seven placebo-controlled, double-blind trials that investigated the efficacy of increasing testosterone levels in men with unequivocally low testosterone, and included the Sexual Function, Physical Function, Vitality, Cognitive Function, Anemia, Bone, and Cardiovascular trials. The median age of men in these trials was 72 years. All men had a baseline testosterone concentration of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneHypogonadismHumansDietary SupplementsHormone Replacement Therapy

Stichwörter der Autor:innen

Hormone Replacement TherapyHypogonadismTestosteroneTherapeutic UsesTreatment Outcome

Substanzen

Testosterone

Autor:innen und Institutionen

  • Department of Urology, Emory University School of Medicine, Atlanta, GA 30332, United States.

Zitieren

APA

Chu, A. T., & Mehta, A. (2024). The implications of supraphysiological testosterone supplementation. The Journal of Sexual Medicine. https://doi.org/10.1093/jsxmed/qdad179

Vancouver

Chu AT, Mehta A. The implications of supraphysiological testosterone supplementation. The Journal of Sexual Medicine. 2024. doi:10.1093/jsxmed/qdad179

BibTeX
@article{Chu2024,
  author = {Chu, Alice T and Mehta, Akanksha},
  title = {The implications of supraphysiological testosterone supplementation},
  journal = {The Journal of Sexual Medicine},
  year = {2024},
  doi = {10.1093/jsxmed/qdad179}
}
Kostenlos starten →